arrow
S

Shigeru Kusumoto

aichi cancer center
H指数:35
被引数:4,645

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A phase 2 trial of CHOP with anti-CCR4 antibody mogamulizumab for older patients with adult T-cell leukemia/lymphoma

一项CHOP联合抗CCR4抗体mogamulizumab治疗老年成人T细胞白血病/淋巴瘤患者的II期临床试验

Blood
IF23.1
2025-05-190
PRE
Outcomes of Cessation of Nucleos(t)ide Analog Administration on Hepatitis B Virus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Retrospective Study
2024-03-010
OAAI
Clinical landscape of TP73 structural variants in ATL patients
LEUKEMIA
IF13.4
2023-10-201
OAAI
Case report: Genomic analysis of a therapy-related chronic myelomonocytic leukemia with KMT2A rearrangement that progressed to acute myeloid leukemia with acute promyelocytic leukemia-like features

病例报告: 具有KMT2A重排的治疗相关慢性粒单核细胞白血病的基因组分析,进展为具有急性早幼粒细胞白血病样特征的急性髓系白血病

2023-02-170
OAAI
Fludarabine plus reduced-intensity busulfan versus fludarabine plus myeloablative busulfan in patients with non-Hodgkin lymphoma undergoing allogeneic hematopoietic cell transplantation
2023-01-121
OAAI
Outcome of nucleos(t)ide analog cessation in patients with treatment for prevention of or against hepatitis B virus reactivation
2022-12-161
PRE
Landscape of immunoglobulin heavy chain γ gene class switch recombination in patients with adult T-cell leukemia-lymphoma
2022-11-240
OAAI
Genomic determinants impacting the clinical outcome of mogamulizumab treatment for adult T-cell leukemia/lymphoma
2022-04-1416
OAAI